Invention Grant
- Patent Title: Methods for diagnosing and treating cancer
-
Application No.: US16591253Application Date: 2019-10-02
-
Publication No.: US11261498B2Publication Date: 2022-03-01
- Inventor: Thomas E. Januario , David Shames
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agent Rahul Vartak
- Main IPC: C12Q1/6886
- IPC: C12Q1/6886 ; A61K31/517
Abstract:
The present invention provides methods of treating cancer based on the methylation status of the ERBB2 gene. One aspect of the invention provides a method of administering an EGFR inhibitor therapy based on the methylation status of the ERBB2 gene.
Public/Granted literature
- US20200024670A1 DIAGNOSTIC MARKERS Public/Granted day:2020-01-23
Information query
IPC分类:
